Green Alpha Advisors’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Sell |
53,308
-7,953
| -13% | -$16.2K | 0.1% | 100 |
|
|
2025
Q1 | $99.9K | Sell |
61,261
-4,185
| -6% | -$6.82K | 0.11% | 102 |
|
|
2024
Q4 | $120K | Buy |
65,446
+33,232
| +103% | +$60.8K | 0.1% | 140 |
|
|
2024
Q3 | $186K | Sell |
32,214
-871
| -3% | -$5.03K | 0.15% | 124 |
|
|
2024
Q2 | $267K | Sell |
33,085
-3,332
| -9% | -$26.9K | 0.21% | 109 |
|
|
2024
Q1 | $505K | Sell |
36,417
-1,227
| -3% | -$17K | 0.37% | 98 |
|
|
2023
Q4 | $230K | Sell |
37,644
-9,860
| -21% | -$60.3K | 0.17% | 142 |
|
|
2023
Q3 | $222K | Buy |
47,504
+32,313
| +213% | +$151K | 0.17% | 139 |
|
|
2023
Q2 | $81.4K | Buy |
15,191
+2,999
| +25% | +$16.1K | 0.05% | 147 |
|
|
2023
Q1 | $120K | Sell |
12,192
-64
| -0.5% | -$630 | 0.08% | 140 |
|
|
2022
Q4 | $229K | Sell |
12,256
-26
| -0.2% | -$486 | 0.19% | 127 |
|
|
2022
Q3 | $254K | Buy |
12,282
+1,399
| +13% | +$28.9K | 0.22% | 129 |
|
|
2022
Q2 | $226K | Buy |
10,883
+4,284
| +65% | +$89K | 0.05% | 142 |
|
|
2022
Q1 | $284K | Buy |
6,599
+545
| +9% | +$23.5K | 0.19% | 125 |
|
|
2021
Q4 | $363K | Buy |
6,054
+623
| +11% | +$37.4K | 0.25% | 117 |
|
|
2021
Q3 | $467K | Buy |
5,431
+217
| +4% | +$18.7K | 0.32% | 119 |
|
|
2021
Q2 | $580K | Buy |
+5,214
| New | +$580K | 0.39% | 112 |
|